The Health Minister has directed the DCGI to punish fake drug-manufacturing firms – Mandaviya has directed the Drugs Controller General of India (DCGI) to take stringent action against all pharmaceutical manufacturing companies that make spurious drugs. “There shall be no compromise with the quality of drugs manufactured in India”, he emphasized
Strongly stressing the need for self-regulation in the MSME pharma sector, the Union Health Minister, Mansukh Mandaviya underscored its importance for India to maintain the status of ‘Pharmacy of the World’. The Health Minister has directed the DCGI to punish fake drug-manufacturing firms , Mandaviya said that India’s global position in the pharmaceutical sector is created through quality products and the country must undertake all possible steps to ensure that it strengthens this position in terms of value and quality hence, the role of self-regulation becomes critical.
“It is important for MSME Pharma Cos. to be alert to the quality of drugs and expeditiously move towards Good Manufacturing Processes (GMP) through self-regulation,” stated Mandaviya as he met representatives from Pharma Companies from the MSME sector on Tuesday.
While assuring the industry, the Centre has taken a major decision of making Schedule M to be compulsory for the MSME pharma sector in a phased manner. The Health Minister has directed the DCGI to punish fake drug-manufacturing firms , “This will help in quality assurance and also reduce compliance burden’, the Union Minister said.
Mandaviya has directed the Drugs Controller General of India (DCGI) to take stringent action against all pharmaceutical manufacturing companies that make spurious drugs. The Health Minister has directed the DCGI to punish fake drug-manufacturing firms , “There shall be no compromise with the quality of drugs manufactured in India”, he emphasized.
Highlighting that the Government has zero tolerance towards manufacturers not adhering to quality compliance and making spurious medicines, he stated that special squads have been formed to inspect drugs making companies and stringent actions have been taken.
The Union Minister further stated that in order to ensure the highest quality of pharma products, the regulatory authorities have started the risk-based inspection and audit of plants. The Health Minister has directed the DCGI to punish fake drug-manufacturing firms He stated that 137 firms were inspected, and action has been taken against 105 firms.
Production has been stopped at 31 firms and Cancellation & Suspension of Product/Section Licenses have been issued against 50 firms. The Health Minister has directed the DCGI to punish fake drug-manufacturing firms In addition, show cause notice has been issued to 73 firms, and warning letters have been issued against 21 firms, the Union Health Minister said.
